Published in N Engl J Med on February 24, 2005
Intracerebral haemorrhage. Lancet (2009) 5.15
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med (2016) 3.88
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med (2011) 2.68
Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology (2011) 2.67
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care (2011) 2.23
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology (2009) 2.23
Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med (2014) 2.09
The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke (2009) 1.89
Coagulation abnormalities in critically ill patients. Crit Care (2006) 1.84
Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists. Neurology (2010) 1.73
Postoperative intracranial haemorrhage: a review. Neurosurg Rev (2011) 1.69
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective. Crit Care (2006) 1.58
Intracerebral haemorrhage: an often neglected medical emergency. Intern Emerg Med (2007) 1.55
Treating the acute stroke patient as an emergency: current practices and future opportunities. Int J Clin Pract (2006) 1.55
The surgical management of chronic subdural hematoma. Neurosurg Rev (2011) 1.54
Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke (2009) 1.46
Warfarin use leads to larger intracerebral hematomas. Neurology (2008) 1.43
The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours. Stroke (2008) 1.43
Emergency neurological care of strokes and bleeds. J Emerg Trauma Shock (2010) 1.39
Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol (2014) 1.37
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry (2005) 1.33
Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis (2013) 1.30
Advances in the management of intracerebral hemorrhage. Nat Rev Neurol (2010) 1.28
Update on intracerebral haemorrhage. J Neurol (2006) 1.19
Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study. J Pediatr (2010) 1.15
CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care (2012) 1.14
Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs (2009) 1.13
Development and validation of a simple conversion model for comparison of intracerebral hemorrhage volumes measured on CT and gradient recalled echo MRI. Stroke (2008) 1.10
Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. J Clin Invest (2008) 1.07
Management of intracerebral hemorrhage. Vasc Health Risk Manag (2007) 1.07
Should direct thrombin inhibitors replace warfarin for prophylaxis of thromboembolism in canadians with atrial fibrillation? Can J Hosp Pharm (2012) 1.07
Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage. Stroke (2013) 1.06
Intracerebral haemorrhage - initial actions are critical. Intern Emerg Med (2007) 1.05
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care (2013) 1.04
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02
Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. J Cereb Blood Flow Metab (2009) 1.00
Hemorrhagic stroke in children. Pediatr Neurol (2007) 0.99
Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care (2010) 0.98
Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ (2010) 0.98
Clinical review: Critical care management of spontaneous intracerebral hemorrhage. Crit Care (2008) 0.96
PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol (2010) 0.95
Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema. Neurocrit Care (2008) 0.93
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients. CMAJ (2008) 0.93
"Dynamic spot sign" on CT perfusion source images predicts haematoma expansion in acute intracerebral haemorrhage. Eur Radiol (2013) 0.93
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Vasc Health Risk Manag (2007) 0.91
Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleeding. Thromb J (2006) 0.90
Intracerebral hemorrhage--improving outcome by reducing volume? N Engl J Med (2008) 0.90
Advances in the management of intracerebral hemorrhage. J Neural Transm (Vienna) (2013) 0.90
Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study. J Neurol (2013) 0.89
SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study. J Vasc Interv Neurol (2012) 0.88
Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care (2008) 0.88
Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery. Tex Heart Inst J (2007) 0.88
Thalamic haemorrhage vs internal capsule-basal ganglia haemorrhage: clinical profile and predictors of in-hospital mortality. BMC Neurol (2007) 0.88
A prototype device for non-invasive continuous monitoring of intracerebral hemorrhage. J Neurosci Methods (2012) 0.87
European research priorities for intracerebral haemorrhage. Cerebrovasc Dis (2011) 0.87
The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework. Transfus Med (2012) 0.86
Research and technology in neurocritical care. Neurocrit Care (2012) 0.86
Intracranial hemorrhage. Am J Respir Crit Care Med (2011) 0.86
Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. JAMA Neurol (2013) 0.86
Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. J Neurol (2008) 0.85
Therapeutic strategies in acute intracerebral hemorrhage. Neurotherapeutics (2012) 0.85
Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant. J Cardiothorac Surg (2007) 0.84
Where will the next generation of stroke treatments come from? PLoS Med (2010) 0.84
Pediatric stroke. Childs Nerv Syst (2011) 0.84
Ischemic-appearing electrocardiographic changes predict myocardial injury in patients with intracerebral hemorrhage. Am J Emerg Med (2011) 0.83
Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage. Stroke (2015) 0.83
Stopping the bleeding in intracerebral hemorrhage. N Engl J Med (2005) 0.83
Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs. Exp Neurol (2008) 0.83
The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage. Stroke (2009) 0.82
Eligibility for the surgical trial in intracerebral hemorrhage II study in a population-based cohort. Neurocrit Care (2008) 0.82
The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications? Thromb J (2010) 0.82
Time course and predictors of neurological deterioration after intracerebral hemorrhage. Stroke (2015) 0.82
Perioperative management of coagulation in nontraumatic intracerebral hemorrhage. Anesthesiology (2013) 0.81
Ethics roundtable debate: patients and surrogates want 'everything done'--what does 'everything' mean? Crit Care (2006) 0.81
Intra-cerebral haemorrhages: are there any differences in baseline characteristics and intra-hospital mortality between hospitaland population-based registries? J Neurol (2009) 0.81
Management of intraventricular hemorrhage. Curr Neurol Neurosci Rep (2010) 0.80
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII. Blood Transfus (2014) 0.80
Rational Use of Recombinant Factor VIIa in Clinical Practice. Indian J Hematol Blood Transfus (2013) 0.80
Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review. J Extra Corpor Technol (2006) 0.80
Intracerebral hemorrhage: toward physiological imaging of hemorrhage risk in acute and chronic bleeding. Front Neurol (2012) 0.80
Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients. Ann Saudi Med (2010) 0.79
Treatment of 817 patients with spontaneous supratentorial intracerebral hemorrhage: characteristics, predictive factors and outcome. Clin Pract (2012) 0.79
Clinical pharmacological issues in the development of acute stroke therapies. Br J Pharmacol (2008) 0.79
Anthropometric approximation of body weight in unresponsive stroke patients. J Neurol Neurosurg Psychiatry (2007) 0.78
Intraventricular Hemorrhage and Early Hematoma Expansion in Patients with Intracerebral Hemorrhage. Sci Rep (2015) 0.78
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings. Crit Care (2005) 0.78
Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol (2014) 0.78
Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent. Neuroradiology (2007) 0.78
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 0.78
The spot sign predicts hematoma expansion, outcome, and mortality in patients with primary intracerebral hemorrhage. J Korean Neurosurg Soc (2014) 0.78
Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes. Crit Care (2006) 0.77
Epidemiological, clinical, and therapeutic aspects of primary intracerebral hemorrhage. Neurol Sci (2008) 0.77
Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage. Ther Adv Neurol Disord (2012) 0.77
Targeting Secondary Hematoma Expansion in Spontaneous Intracerebral Hemorrhage - State of the Art. Front Neurol (2016) 0.77
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology (2006) 4.88
Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med (2012) 3.81
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol (2003) 3.58
Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis (2009) 3.01
The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56
Plague dynamics are driven by climate variation. Proc Natl Acad Sci U S A (2006) 2.51
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37
Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke (2002) 2.36
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage. World Neurosurg (2011) 2.11
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79
Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke (2004) 1.78
Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke (2006) 1.76
Plague and the human flea, Tanzania. Emerg Infect Dis (2007) 1.71
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. J Neurosurg (2008) 1.68
Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med (2012) 1.67
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke (2005) 1.65
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
Baroreflex: a new therapeutic target in human stroke? Stroke (2009) 1.62
Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg (2005) 1.61
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke (2004) 1.60
Surgery for catastrophic epilepsy in infants 6 months of age and younger. J Neurosurg Pediatr (2010) 1.55
NIHSS training and certification using a new digital video disk is reliable. Stroke (2005) 1.53
Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. Stroke (2008) 1.52
Diagnostic yield of computed tomography angiography and magnetic resonance angiography in patients with catheter angiography-negative subarachnoid hemorrhage. J Neurosurg (2012) 1.52
Climatically driven synchrony of gerbil populations allows large-scale plague outbreaks. Proc Biol Sci (2007) 1.51
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Comparison of the European and Japanese guidelines for the management of ischemic stroke. Cerebrovasc Dis (2013) 1.47
A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients. Neurocrit Care (2011) 1.47
Autonomic shift and increased susceptibility to infections after acute intracerebral hemorrhage. Stroke (2011) 1.46
Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg (2011) 1.44
Ischaemic stroke: the ocular motor system as a sensitive marker for motor and cognitive recovery. J Neurol Neurosurg Psychiatry (2012) 1.43
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care (2007) 1.42
Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke (2005) 1.41
Withholding care in intracerebral hemorrhage: realistic compassion or self-fulfilling prophecy? Neurology (2007) 1.41
Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma (2008) 1.40
Evidence-based medicine: what do you do when there's no evidence? Crit Care Med (2003) 1.39
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran. Thromb Haemost (2015) 1.36
Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab (2006) 1.34
Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology (2006) 1.33
Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care (2006) 1.31
Late childhood stuttering. J Speech Lang Hear Res (2008) 1.30
Hypothermia for refractory status epilepticus. Neurocrit Care (2008) 1.30
Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol (2003) 1.27
Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke (2007) 1.26
The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable. J Clin Neurosci (2002) 1.26
Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke (2005) 1.25
The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care (2008) 1.25
Sensitivity to changes in disability after stroke: a comparison of four scales useful in clinical trials. J Rehabil Res Dev (2004) 1.24
Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke (2007) 1.24
Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab (2006) 1.22
Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis (2002) 1.21
Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke (2004) 1.20
Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke (2005) 1.18
West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation (2004) 1.18
Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg (2002) 1.18
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16